AACR Annual Meeting 2017: Challenging the Dogma of Treating IDH-mutant Cancers With IDH Inhibitors
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
Hugh Gannon, PhD, a recipient of the 2013 Anna D. Barker Fellowship in Basic Cancer Research, is studying p53's...